| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |